Dina Fine Maron
Does the US have the biotechnology and other tools to deal with the next wave of diseases?
[Editor's note: Tom Frieden served seven and a half years as director of the U.S. Centers for Disease Control and Prevention ...
Many doctors reluctant to embrace personalized medicine
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Tailoring treatments to genetic ...
Mixed response from patient advocacy groups on prospects of gene editing therapies
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. The revolutionary gene-editing technology ...
How much power do we have over our own gut microbiome?
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. We may be able ...
What would it take to cure cancer?
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. On January 12 Pres ...
Obesity may be causing earlier puberty in girls
For the past two decades scientists have been trying to unravel a mystery in young girls. Breast development, typical of ...
Mom’s pregnancy diet affects her children and grandchildren
What mom eats during pregnancy dramatically influences not only the health of her kids but future generations as well. That’s ...
How will parents deal with fetal genome screening?
Today’s genetic technologies are not yet a crystal ball for seeing a child’s future, but doctors are closer than ever ...
FTC charges GeneLink with false advertising
It sounded like a miracle of science and convenience: swab your cheek and drop the saliva sample in the mailbox ...
Is limb regeneration science fiction? Maybe not
Limb regeneration remains the stuff of science fiction for humans, but an accidental discovery suggests people may yet be able ...
Military blood serum bank advances research, raises privacy concerns
The US Department of Defense's huge blood serum bank is great for scientific research, but not all donors know they're ...
NIH begins gene therapy trial for Parkinson’s disease
All eyes were on Perry Cohen when he froze at the microphone. His voice failed him. He couldn’t read his ...
